Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion Mar 25, 2024 9:41am

52 Views

Post# 35950437

Like LABS business in Germany, I see we are "very robust"

here today as well. After Germany 'rescheduling', I'm pretty sure Vice President Kamala Harris told us the DEA is next for the U.S. market.

PLEASE, do not forget, LABS is the only FDA approved source in North America for PHARMACEUTICAL CANNABINOID BASED MOLECULES.

Any idea who funded over $80 million CAD on those over "20 strong clinical trials" because the LABS balance sheet has no debt to correlate to it financially.

<< Previous

Bullboard Posts

Next >>

Why Roth Capital Partners gives GameSquare a 'buy' rating